Yuyu Pharma Inc Cash Flow-to-Debt Ratio
Yuyu Pharma Inc cash flow-to-debt ratio. Yuyu Pharma Inc (000225) has a Cash Flow-to-Debt Ratio of 0.08x as of June 2026, meaning its operating cash flow of ₩4.91 Billion could theoretically repay 0% of its total liabilities (₩61.70 Billion) in one year. Check cash flow quality index of Yuyu Pharma Inc to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Yuyu Pharma Inc (2014–2025)
Cash flow-to-debt ratio of Yuyu Pharma Inc from 2014 to 2025. Historical debt coverage capacity for Yuyu Pharma Inc across 12 annual periods. Check Yuyu Pharma Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Yuyu Pharma Inc Cash Flow-to-Debt Ratio by Year (2014–2025)
Yuyu Pharma Inc cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Yuyu Pharma Inc. For the full cash flow conversion analysis, see cash flow conversion of Yuyu Pharma Inc.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.24x | ₩15.88 Billion | ₩66.68 Billion | ▼ -30.7% |
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | — |